CHF28.60
2.14% yesterday
SIX Swiss Exchange, Nov 15, 05:31 pm CET
ISIN
CH0461929603
Symbol
XLS
Sector
Industry

Xlife Sciences Target price 2024 - Analyst rating & recommendation

Xlife Sciences Classifications & Recommendation:

Buy
100%

Xlife Sciences Price Target

Target Price CHF68.00
Price CHF28.60
Potential
Number of Estimates 1
1 Analyst has issued a Xlife Sciences price target 2025. The average Xlife Sciences target price is CHF68.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend Xlife Sciences to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Xlife Sciences stock has an average upside potential 2025 of . Most analysts recommend the Xlife Sciences stock at Purchase.

Sales and Margin forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million CHF 0.99 0.80
3.88% 19.19%
EBITDA Margin -442.42% -503.79%
12.20% 13.87%
Net Margin 1,571.82% -454.22%
4.42% 128.90%

1 Analyst has issued a sales forecast Xlife Sciences 2024 . The average Xlife Sciences sales estimate is

CHF800k
Unlock
. This is
19.19% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CHF800k 19.19%
Unlock
, the lowest is
CHF800k 19.19%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 CHF990k 3.88%
2024
CHF800k 19.19%
Unlock
2025
CHF806k 0.76%
Unlock

1 Analyst has issued an EBITDA forecast Xlife Sciences 2024 . The average Xlife Sciences EBITDA estimate is

CHF-4.0m
Unlock
. This is
50.95% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
CHF-4.0m 50.95%
Unlock
, the lowest is
CHF-4.0m 50.95%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 CHF-4.4m 15.61%
2024
CHF-4.0m 7.98%
Unlock
2025
CHF-3.9m 4.00%
Unlock

EBITDA Margin

2023 -442.42% 12.20%
2024
-503.79% 13.87%
Unlock
2025
-479.98% 4.73%
Unlock

1 Analyst has issued a net profit forecast Xlife Sciences 2024 . The average Xlife Sciences net profit estimate is

CHF-3.6m
Unlock
. This is
116.76% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CHF-3.6m 116.76%
Unlock
, the lowest is
CHF-3.6m 116.76%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 CHF15.6m 0.37%
2024
CHF-3.6m 123.33%
Unlock
2025
CHF-3.3m 7.99%
Unlock

Net Margin

2023 1,571.82% 4.42%
2024
-454.22% 128.90%
Unlock
2025
-414.96% 8.64%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share CHF 2.73 -0.66
0.37% 124.18%
P/E negative
EV/Sales 503.65

1 Analysts have issued a Xlife Sciences forecast for earnings per share. The average Xlife Sciences <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

CHF-0.66
Unlock
. This is
117.37% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
CHF-0.66 117.37%
Unlock
, the lowest is
CHF-0.66 117.37%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 CHF2.73 0.37%
2024
CHF-0.66 124.18%
Unlock
2025
CHF-0.61 7.58%
Unlock

P/E ratio

Current 7.54 37.84%
2024
-68.16 1,003.98%
Unlock
2025
-74.05 8.64%
Unlock

Based on analysts' sales estimates for 2024, the Xlife Sciences stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

503.65
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
309.81
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 316.88 11.74%
2024
503.65 58.94%
Unlock
2025
499.84 0.76%
Unlock

P/S ratio

Current 165.87 18.68%
2024
309.81 86.78%
Unlock
2025
307.47 0.76%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today